Teva signs $2.3b credit facility deal

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that it has entered into a new $2.3 billion unsecured revolving credit facility, which replaces its existing $3 billion credit facility. Teva EVP and CFO…